Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Novavax Inc NVAX

Healthcare Biotechnology
Novavax, Inc. is a biotechnology company, which discovers, develops and commercializes vaccines to prevent serious infectious diseases. The Company offers a differentiated vaccine platform that combines a recombinant protein approach, advanced nanoparticle technology and its patented Matrix-M adjuvant to enhance the immune response. It has one commercial program, for vaccines to prevent COVID... see more

Recent & Breaking News (NDAQ:NVAX)

Novavax Produces MERS-CoV Vaccine Candidate

Globe Newswire June 6, 2013

Novavax Announces Public Offer for All Outstanding Shares of Isconova

Globe Newswire June 4, 2013

Wall Street Fundamentals Releases New In-Depth Stock Reports on ARRY, INFI, ISIS and NVAX

Accesswire June 3, 2013

Flexion Therapeutics Names Frederick Driscoll Chief Financial Officer

PR Newswire May 20, 2013

Novavax H7N9 VLP Influenza Vaccine Enters Animal Testing

Globe Newswire May 10, 2013

Novavax Reports First-Quarter 2013 Financial Results

Globe Newswire May 7, 2013

Novavax to Report First-Quarter 2013 Financial Results on May 7, 2013

Globe Newswire April 26, 2013

Novavax to Present at 12th Annual Needham Healthcare Conference

Globe Newswire April 25, 2013

MannKind, Ariad Pharma, Ziopharm Oncology, Galena Biopharma, and Novavax Under StockCall's Microscope

PR Newswire April 23, 2013

Novavax to Review Recent Findings from Vaccine Programs at World Vaccine Congress and Expo in Washington, DC

Globe Newswire April 15, 2013

Novavax Appoints Amy B. Fix Vice President of Regulatory Affairs

Globe Newswire April 10, 2013

Free Research Reports on ARNA, MT, NVAX and SNTS Issued by the Paragon Report

Marketwired April 4, 2013

Novavax Reports Positive Top-Line Results From Phase II Clinical Trial of RSV Vaccine Candidate in Women of Childbearing Age

Globe Newswire April 2, 2013

Morning Research on Arena Pharma, Incyte, Galena Biopharma, and Novavax

PR Newswire March 19, 2013

Novavax Reports Progress on RSV Vaccine at the XV International Symposium on Respiratory Viral Infections

Troy Schwensen March 18, 2013

Novavax to Present at the 25th Annual ROTH Conference

Troy Schwensen March 13, 2013

New Programs Designed to Speed Up Approval Process a Key Factor in Biotech Industry's Growth in 2012

Marketwired March 11, 2013

Novavax, CPLB and ICGEB Collaboration Honored for Malaria Vaccine Progress at Vaccine World Summit India 2013

Troy Schwensen March 8, 2013

Novavax to Report 2012 Fourth-Quarter and Year-End Financial Results on March 1, 2013

Troy Schwensen February 22, 2013

Sharp Increase in FDA Drug Approvals a Major Factor in Biotech Industry's Success

Marketwired February 8, 2013